Similar articles

• Con: tranexamic acid is not better than aprotinin in decreasing bleeding after cardiac surgery.

  Murkin JM. Murkin JM. J Cardiothorac Vasc Anesth. 1994 Aug;8(4):474-6. doi: 10.1016/1053-0770(94)90292-5. J Cardiothorac Vasc Anesth. 1994. PMID: 7524720 Review. No abstract available.
• Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.

  Casati V, Guzzon D, Oppizzi M, Bellotti F, Franco A, Gerli C, Cossolini M, Torri G, Calori G, Benussi S, Alfieri O. Casati V, et al. J Thorac Cardiovasc Surg. 2000 Sep;120(3):520-7. doi: 10.1067/mtc.2000.108016. J Thorac Cardiovasc Surg. 2000. PMID: 10962414 Clinical Trial.
• Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?

  Bulutcu FS, Ozbek U, Polat B, Yalçin Y, Karaci AR, Bayindir O. Bulutcu FS, et al. Paediatr Anaesth. 2005 Jan;15(1):41-6. doi: 10.1111/j.1460-9592.2004.01366.x. Paediatr Anaesth. 2005. PMID: 15649162 Clinical Trial.
• Comparison of blood-conservation strategies in cardiac surgery patients at high risk for bleeding.

  Nuttall GA, Oliver WC, Ereth MH, Santrach PJ, Bryant SC, Orszulak TA, Schaff HV. Nuttall GA, et al. Anesthesiology. 2000 Mar;92(3):674-82. doi: 10.1097/00000542-200003000-00010. Anesthesiology. 2000. PMID: 10719945 Clinical Trial.
• Aprotinin is useful as a hemostatic agent in cardiopulmonary surgery: no.

  Karkouti K, Beattie WS. Karkouti K, et al. J Thromb Haemost. 2006 Sep;4(9):1879-81. doi: 10.1111/j.1538-7836.2006.02106.x. Epub 2006 Jun 27. J Thromb Haemost. 2006. PMID: 16803464 Review. No abstract available.